| Scandals in Biomedical Research |
| Written by Victoria Parente |
| Wednesday, 21 October 2009 08:35 |
|
{description}Fraudulent data published to substantiate the effectiveness of Merck & Co.’s painkiller Vioxx and stem cell line production in South Korea have undermined the public’s trust. Are unethical cases in the life sciences industry just a few outlying, extreme examples giving research a bad name?{/description} |
